Brokerages Set Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Price Target at $17.25
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the five analysts that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, three have given a buy rating and one has issued a strong buy rating on the […]
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the five analysts that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, three have given a buy rating and one has issued a strong buy rating on the […]
